Correlation Between Abattis Bioceuticals and Pharmagreen Biotech

Can any of the company-specific risk be diversified away by investing in both Abattis Bioceuticals and Pharmagreen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abattis Bioceuticals and Pharmagreen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abattis Bioceuticals Corp and Pharmagreen Biotech, you can compare the effects of market volatilities on Abattis Bioceuticals and Pharmagreen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abattis Bioceuticals with a short position of Pharmagreen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abattis Bioceuticals and Pharmagreen Biotech.

Diversification Opportunities for Abattis Bioceuticals and Pharmagreen Biotech

0.0

Correlation Coefficient

Abattis Bioceuticals  Pharmagreen Biotech

Pay attention - limited upside

The 3 months correlation between Abattis and Pharmagreen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abattis Bioceuticals Corp and Pharmagreen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmagreen Biotech and Abattis Bioceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abattis Bioceuticals Corp are associated (or correlated) with Pharmagreen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmagreen Biotech has no effect on the direction of Abattis Bioceuticals i.e., Abattis Bioceuticals and Pharmagreen Biotech go up and down completely randomly.

Pair Corralation between Abattis Bioceuticals and Pharmagreen Biotech

If you would invest  0.11  in Pharmagreen Biotech on September 4, 2024 and sell it today you would earn a total of  0.07  from holding Pharmagreen Biotech or generate 63.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Abattis Bioceuticals Corp  vs.  Pharmagreen Biotech

Abattis Bioceuticals Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abattis Bioceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Abattis Bioceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pharmagreen Biotech

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmagreen Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, Pharmagreen Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Abattis Bioceuticals and Pharmagreen Biotech

The main advantage of trading using opposite Abattis Bioceuticals and Pharmagreen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abattis Bioceuticals position performs unexpectedly, Pharmagreen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmagreen Biotech will offset losses from the drop in Pharmagreen Biotech's long position.

The idea behind Abattis Bioceuticals Corp and Pharmagreen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.